- Report
- April 2023
- 394 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- April 2023
- 200 Pages
United States
From €3625EUR$3,750USD£3,114GBP
Gliadel is a brand of chemotherapy drug used to treat brain cancer. It is a wafer that is implanted directly into the brain tumor during surgery. The wafer contains a chemotherapy drug called carmustine, which is slowly released over time. The drug is designed to kill cancer cells and reduce the size of the tumor. Gliadel is used in combination with other treatments, such as radiation therapy and surgery, to improve the chances of survival.
Gliadel is a part of the larger brain cancer drug market, which includes a variety of treatments, such as chemotherapy, radiation therapy, and immunotherapy. The market is highly competitive, with many companies offering different treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Show Less Read more